Literature DB >> 16842136

Definitions of metabolic syndrome: Where are we now?

Stella S Daskalopoulou1, Vassilis G Athyros, Genovefa D Kolovou, Katherine K Anagnostopoulou, Dimitri P Mikhailidis.   

Abstract

The metabolic syndrome (MetS) is a cluster of metabolic abnormalities including abdominal obesity, glucose intolerance, hypertension and dyslipidaemia and is associated with an increased risk of vascular events. Since the initial description of the MetS, several expert groups produced different definitions. This variability led to confusion and absence of comparability between studies. Although there is agreement that the MetS is a major public health challenge worldwide and consistent evidence stresses the need for intervention, the definition of the syndrome remains a matter of debate. This review considers the different definitions of the MetS. These include those proposed by the World Health Organisation, the European Group for the Study of Insulin Resistance, the National Cholesterol Education Program Adult Treatment Panel III, the American College of Endocrinology and American Association of Clinical Endocrinologists and the latest International Diabetes Federation definition which includes ethnic-specific waist circumference cut-off points. These definitions share several features but also include important differences; all have limitations. Selected (after a Medline search) studies comparing the different definitions are also considered. There is a need for a standardised definition of the MetS. Furthermore, a definition tailored for children and adolescents is essential. Prospective long-term studies are needed to validate the prognostic power of these definitions. As new information becomes available the definition of the MetS might be further modified.

Entities:  

Mesh:

Year:  2006        PMID: 16842136     DOI: 10.2174/157016106777698450

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  10 in total

1.  Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome.

Authors:  Donghao Zhou; Hongjun Liu; Ming'ai Zhou; Shengxiang Wang; Jingling Zhang; Lin Liao; Fang He
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

2.  Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population.

Authors:  Dalia Ieva Luksiene; Migle Baceviciene; Abdonas Tamosiunas; Regina Reklaitiene; Ricardas Radisauskas
Journal:  Int J Public Health       Date:  2011-03-08       Impact factor: 3.380

3.  Application of multiscale entropy in arterial waveform contour analysis in healthy and diabetic subjects.

Authors:  An-Bang Liu; Hsien-Tsai Wu; Chun-Wei Liu; Cyuan-Cin Liu; Chieh-Ju Tang; I-Ting Tsai; Cheuk-Kwan Sun
Journal:  Med Biol Eng Comput       Date:  2014-10-29       Impact factor: 2.602

4.  Dynapenia and Metabolic Health in Obese and Nonobese Adults Aged 70 Years and Older: The LIFE Study.

Authors:  Mylène Aubertin-Leheudre; Stephen Anton; Daniel P Beavers; Todd M Manini; Roger Fielding; Ann Newman; Tim Church; Stephen B Kritchevsky; David Conroy; Mary M McDermott; Anda Botoseneanu; Michelle E Hauser; Marco Pahor
Journal:  J Am Med Dir Assoc       Date:  2016-11-30       Impact factor: 4.669

5.  Long-term temporal trends in cardiovascular and metabolic risk factors.

Authors:  Wegene Borena; Tanja Stocks; Susanne Strohmaier; Alexander Strasak; Jonas Manjer; Dorthe Johansen; Håkan Jonsson; Kilian Rapp; Hans Concin; Göran Hallmans; Pär Stattin; Hanno Ulmer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study.

Authors:  Pinchia Huang; Aldi T Kraja; Weihong Tang; Steven C Hunt; Kari E North; Cora E Lewis; Richard B Devereux; Giovanni de Simone; Donna K Arnett; Treva Rice; Dabeeru C Rao
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

7.  COSEHC global vascular risk management quality improvement program: rationale and design.

Authors:  Carlos M Ferrario; Michael A Moore; William Bestermann; Chris Colby; Alex Exuzides; Debra Simmons; Sumeet Panjabi
Journal:  Vasc Health Risk Manag       Date:  2010-12-13

8.  The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.

Authors:  Carlos M Ferrario; Janae Joyner; Chris Colby; Alex Exuzides; Michael Moore; Debra Simmons; William Bestermann; Feride Frech-Tamas
Journal:  Vasc Health Risk Manag       Date:  2013-07-22

9.  Defining genetic determinants of the Metabolic Syndrome in the Framingham Heart Study using association and structural equation modeling methods.

Authors:  Nora L Nock; Xuefeng Wang; Cheryl L Thompson; Yeunjoo Song; Dan Baechle; Paola Raska; Catherine M Stein; Courtney Gray-McGuire
Journal:  BMC Proc       Date:  2009-12-15

10.  Effects of Daily Kelp (Laminaria japonica) Intake on Body Composition, Serum Lipid Levels, and Thyroid Hormone Levels in Healthy Japanese Adults: A Randomized, Double-Blind Study.

Authors:  Seiichiro Aoe; Chiemi Yamanaka; Hirofumi Ohtoshi; Fumiko Nakamura; Suguru Fujiwara
Journal:  Mar Drugs       Date:  2021-06-22       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.